systemic scleroderma造句

例句与造句

1. Thus, a positive anti-centromere antibody finding is strongly suggestive of limited systemic scleroderma.
2. When Jackson vomits blood, the diagnosis reaches systemic scleroderma, which is very difficult to treat.
3. Monsky had systemic scleroderma, a chronic and painful disease afflicting the connective tissues, for two decades.
4. Saville is a systemic Scleroderma patient and is very active in raising funds to find a cure for this disease.
5. The cause was systemic scleroderma, said Charles Spaulding, a vice president of the organization, the Scleroderma Research Foundation, which Monsky founded in 1987.
6. It's difficult to find systemic scleroderma in a sentence. 用systemic scleroderma造句挺难的
7. In systemic scleroderma, the incidence has been estimated to be 8 to 12 % of all patients; in rheumatoid arthritis it is rare.
8. Anti-centromere antibodies are found in approximately 60 % of patients with limited systemic scleroderma and in 15 % of those with the diffuse form of scleroderma.
9. In the United States, the prevalence of systemic scleroderma is about 50, 000, with different studies giving different estimates, usually ranging between 40, 000 and 165, 000.
10. Systemic scleroderma, for example, a disease of the connective tissue that results in hyperproduction of collagen, can sometimes wreak unstoppable havoc on the body's organs, hardening them into woodlike uselessness.
11. It is associated with detectable antibodies against centromeres ( a component of the cell nucleus ), and usually spares the kidneys ( a feature more common in the related condition systemic scleroderma ).
12. Most people with erythromelalgia never go into remission and the symptoms are ever present at some level, whilst others get worse, or the EM is eventually a symptom of another disease such as systemic scleroderma.
13. The programs support research in rheumatoid arthritis; adjuvant and chemically induced inflammatory arthritis; systemic lupus erythematosus; systemic scleroderma; spondyloarthropathies; dermatomyositis and myositis; vasculitis; fibromyalgia; juvenile arthritis and general autoimmunity; gout; Lyme disease; and infection-related arthritis.
14. Mutations in super-enhancers have been noted in various diseases, including cancers, type 1 diabetes, Alzheimer s disease, lupus, rheumatoid arthritis, multiple sclerosis, systemic scleroderma, primary biliary cirrhosis, Crohn s disease, Graves disease, vitiligo, and atrial fibrillation.